Stryker Corporation (SYK) has experienced challenges in growth. The company operates in the Healthcare sector, specifically in the Medical Devices industry.
Over the past 4 years, Stryker Corporation has achieved a revenue compound annual growth rate (CAGR) of 44.1%, while earnings have grown at 39.6% CAGR.
Historical revenue and profitability trends for Stryker Corporation
The chart above illustrates Stryker Corporation's revenue trajectory over the past 4 years. The revenue pattern shows the challenges the company has faced in recent periods.
Annual percentage change in revenue and earnings
Growth rates provide insight into the momentum of Stryker Corporation's business.
How efficiently Stryker Corporation converts revenue into profit
Profit margins reveal how much of each dollar of revenue Stryker Corporation retains at different stages:
Analyst estimates and forward-looking indicators
Wall Street analysts project Stryker Corporation to continue growing earnings in the coming year. The consensus analyst rating is 4.0625 based on 32 analysts.
Based on our comprehensive analysis, Stryker Corporation (SYK) demonstrates declining growth characteristics.
This growth analysis provides a comprehensive view of Stryker Corporation's historical performance and future outlook. Investors should consider these growth metrics alongside valuation, competitive positioning, and broader market conditions when making investment decisions. Past performance does not guarantee future results.
See how Stryker Corporation stacks up against similar companies
Explore growth analysis for top stocks
Related: SYK Valuation, SYK Dividend, SYK Financial Health
Compare: SYK vs AAPL, SYK vs MSFT, SYK vs GOOGL